New hope for breast cancer survivors: radiofrequency may ease menopause symptoms without hormones
NCT ID NCT07034976
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a non-surgical radiofrequency device, combined with pelvic floor exercises, can reduce vaginal dryness and other menopause-related symptoms in breast cancer survivors. Fifty women will receive either active or sham radiofrequency once a week for six weeks, plus guided exercises. Researchers will measure symptom changes at the end of treatment and three months later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
non-ablative radiofrequency (Capenergy C500 device) plus pelvic floor muscle training
What this could lead to
If it works, this could offer a non-hormonal option to ease vaginal dryness and discomfort in breast cancer survivors who cannot use estrogen therapy.
What could go wrong
This is a small early trial with only 50 participants, so results may not apply to everyone. The sham group also gets exercise, so the added benefit of radiofrequency may be small or unclear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, Madrid, 28034, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••